In addition, according to western blot results, expression of epithelial marker, E-cadherin, showed significant upregulation, while expression of mesenchymal marker, N-cadherin, showed downregulation under silencing PCGEM1 in NSCLC cells (Fig. 1H). The gene discussed is CDH2; the disease is non-small cell lung carcinoma.